MTBT

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 562673

CAS#: 1110905-26-4

Description: MTBT is an inhibitor of the proliferation of cancer cells. It induces cell cycle arrest and activates p38 MAPK.


Chemical Structure

img
MTBT
CAS# 1110905-26-4

Theoretical Analysis

MedKoo Cat#: 562673
Name: MTBT
CAS#: 1110905-26-4
Chemical Formula: C14H11NO2S2
Exact Mass: 289.0231
Molecular Weight: 289.36
Elemental Analysis: C, 58.11; H, 3.83; N, 4.84; O, 11.06; S, 22.16

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: MTBT;

IUPAC/Chemical Name: 2-(3-Methylthiophen-2-yl)-4-(3,4-dihydroxyphenyl)thiazole

InChi Key: GPOLRXTYEHGQTM-UHFFFAOYSA-N

InChi Code: InChI=1S/C14H11NO2S2/c1-8-4-5-18-13(8)14-15-10(7-19-14)9-2-3-11(16)12(17)6-9/h2-7,16-17H,1H3

SMILES Code: OC1=CC=C(C2=CSC(C3=C(C)C=CS3)=N2)C=C1O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 289.36 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Zhang J, Zhang X, Wu L, Wang T, Zhao J, Zhang Y, Men Z, Mao H. Occurrence of benzothiazole and its derivates in tire wear, road dust, and roadside soil. Chemosphere. 2018 Jun;201:310-317. doi: 10.1016/j.chemosphere.2018.03.007. Epub 2018 Mar 3. PubMed PMID: 29525659.

2: Pugliese M, Ramsay T, Johnson D, Dowlatshahi D. Mobile tablet-based therapies following stroke: A systematic scoping review of administrative methods and patient experiences. PLoS One. 2018 Jan 23;13(1):e0191566. doi: 10.1371/journal.pone.0191566. eCollection 2018. Review. PubMed PMID: 29360872; PubMed Central PMCID: PMC5779660.

3: Pugliese M, Johnson D, Dowlatshahi D, Ramsay T. Mobile tablet-based therapies following stroke: a systematic scoping review protocol of attempted interventions and the challenges encountered. Syst Rev. 2017 Nov 2;6(1):219. doi: 10.1186/s13643-017-0620-6. PubMed PMID: 29096723; PubMed Central PMCID: PMC5669017.

4: Wejnarska K, Kołodziejczyk E, Ryżko J, Oracz G. Comparison of 72-hour fecal fat quantification and the 13C-mixed triglyceride breath test in assessing pancreatic exocrine sufficiency in children with chronic pancreatitis. Dev Period Med. 2016;20(3):222-227. PubMed PMID: 27941193.

5: Gliwicz D, Jankowska I, Wierzbicka A, Miśkiewicz-Chotnicka A, Lisowska A, Walkowiak J. Exocrine pancreatic function in children with Alagille syndrome. Sci Rep. 2016 Oct 17;6:35229. doi: 10.1038/srep35229. PubMed PMID: 27748459; PubMed Central PMCID: PMC5066201.

6: Zhang T, Chen Y, Leiknes T. Oxidation of Refractory Benzothiazoles with PMS/CuFe2O4: Kinetics and Transformation Intermediates. Environ Sci Technol. 2016 Jun 7;50(11):5864-73. doi: 10.1021/acs.est.6b00701. Epub 2016 May 13. PubMed PMID: 27144396.

7: Hornung MW, Kosian PA, Haselman JT, Korte JJ, Challis K, Macherla C, Nevalainen E, Degitz SJ. In Vitro, Ex Vivo, and In Vivo Determination of Thyroid Hormone Modulating Activity of Benzothiazoles. Toxicol Sci. 2015 Aug;146(2):254-64. doi: 10.1093/toxsci/kfv090. Epub 2015 May 7. PubMed PMID: 25953703.

8: Ye Y, Weiwei J, Na L, Mei M, Kaifeng R, Zijian W. Application of the SOS/umu test and high-content in vitro micronucleus test to determine genotoxicity and cytotoxicity of nine benzothiazoles. J Appl Toxicol. 2014 Dec;34(12):1400-8. doi: 10.1002/jat.2972. Epub 2014 Jan 30. PubMed PMID: 24478133.

9: Li Y, Zhang X, Zhang J, Li Y, Liu W, Wang Z, Wang Y, Si S. A small molecule, MTBT, prevents cancer cell growth by activating p38 MAPK. Anticancer Drugs. 2014 Apr;25(4):423-32. doi: 10.1097/CAD.0000000000000074. PubMed PMID: 24441745; PubMed Central PMCID: PMC4091034.

10: Nawarathne IN, Walker KD. Point mutations (Q19P and N23K) increase the operational solubility of a 2alpha-O-benzoyltransferase that conveys various acyl groups from CoA to a taxane acceptor. J Nat Prod. 2010 Feb 26;73(2):151-9. doi: 10.1021/np900524d. PubMed PMID: 20108947.

11: Matamoros V, Jover E, Bayona JM. Occurrence and fate of benzothiazoles and benzotriazoles in constructed wetlands. Water Sci Technol. 2010;61(1):191-8. doi: 10.2166/wst.2010.797. PubMed PMID: 20057105.

12: Hintz H, Peisert H, Aygül U, Latteyer F, Biswas I, Nagel P, Merz M, Schuppler S, Breusov D, Allard S, Scherf U, Chassé T. Electronic structure and interface properties of a model molecule for organic solar cells. Chemphyschem. 2010 Jan 18;11(1):269-75. doi: 10.1002/cphc.200900626. PubMed PMID: 19937666.

13: Valente R, Testi A, Tanfani E, Fato M, Porro I, Santo M, Santori G, Torre G, Ansaldo G. A model to prioritize access to elective surgery on the basis of clinical urgency and waiting time. BMC Health Serv Res. 2009 Jan 1;9:1. doi: 10.1186/1472-6963-9-1. PubMed PMID: 19118494; PubMed Central PMCID: PMC2651867.

14: Chipinda I, Zhang XD, Simoyi RH, Siegel PD. Mercaptobenzothiazole allergenicity-role of the thiol group. Cutan Ocul Toxicol. 2008;27(2):103-16. doi: 10.1080/15569520701713008. PubMed PMID: 18568896.

15: Williams SG. Characterization of the behavior of three definitions of prostate-specific antigen-based biochemical failure in relation to detection and follow-up biases: comparison with the American Society for Therapeutic Radiology and Oncology consensus definition. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):849-55. Epub 2005 Oct 13. PubMed PMID: 16226401.

16: Kloepfer A, Jekel M, Reemtsma T. Occurrence, sources, and fate of benzothiazoles in municipal wastewater treatment plants. Environ Sci Technol. 2005 May 15;39(10):3792-8. PubMed PMID: 15952387.

17: Nawrocki ST, Drake KD, Watson CF, Foster GD, Maier KJ. Comparative aquatic toxicity evaluation of 2-(thiocyanomethylthio)benzothiazole and selected degradation products using Ceriodaphnia dubia. Arch Environ Contam Toxicol. 2005 Apr;48(3):344-50. Epub 2005 Feb 15. PubMed PMID: 15750776.

18: Williams SG. Ambiguities within the ASTRO consensus definition of biochemical failure: never assume all is equal. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1083-92. PubMed PMID: 15001248.

19: Perri F, Andriulli A. "Mixed" triglyceride breath test: methodological problems and clinical applications. Rev Med Univ Navarra. 1998 Apr-Jun;42(2):99-103. Review. PubMed PMID: 10420946.